Tecogen Inc. (TGEN)
NYSEAMERICAN: TGEN · Real-Time Price · USD
3.500
-0.070 (-1.96%)
Aug 18, 2026, 4:00 PM EDT - Market closed
Tecogen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 24.58 | 27.07 | 22.62 | 25.14 | 25 | 24.4 | |
Revenue Growth | -6.45% | 19.69% | -10.02% | 0.55% | 2.48% | -13.65% |
Cost of Revenue | 15.68 | 17.25 | 12.75 | 14.94 | 13.94 | 12.81 |
Gross Profit | 8.9 | 9.82 | 9.87 | 10.2 | 11.07 | 11.59 |
Selling, General & Admin | 17.02 | 15.79 | 13.24 | 13.81 | 12.72 | 12.27 |
Research & Development | 1.29 | 1.17 | 0.96 | 0.84 | 0.73 | 0.54 |
Operating Expenses | 18.31 | 16.96 | 14.2 | 14.65 | 13.45 | 12.81 |
Operating Income | -9.41 | -7.13 | -4.33 | -4.45 | -2.39 | -1.22 |
Interest Expense | -0.15 | -0.15 | -0.09 | -0.02 | -0.02 | -0.01 |
Other Non Operating Income (Expenses) | 0.26 | 0.15 | -0.03 | -0.06 | -0.03 | -0.02 |
EBT Excluding Unusual Items | -9.3 | -7.13 | -4.45 | -4.53 | -2.44 | -1.26 |
Impairment of Goodwill | -1.1 | -1.1 | -0.22 | - | - | - |
Gain (Loss) on Sale of Investments | 0.05 | 0.01 | - | - | 0.02 | -0.03 |
Gain (Loss) on Sale of Assets | -0.01 | -0 | 0.01 | 0.04 | 0.04 | 0.01 |
Asset Writedown | -0.02 | -0.02 | - | - | -0 | -0.01 |
Other Unusual Items | - | - | - | - | - | 5.05 |
Pretax Income | -10.36 | -8.23 | -4.65 | -4.49 | -2.38 | 3.76 |
Income Tax Expense | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 |
Earnings From Continuing Operations | -10.38 | -8.25 | -4.67 | -4.52 | -2.4 | 3.74 |
Minority Interest in Earnings | -0.02 | 0 | -0.09 | -0.07 | -0.05 | -0.05 |
Net Income | -10.39 | -8.25 | -4.76 | -4.6 | -2.45 | 3.7 |
Net Income to Common | -10.39 | -8.25 | -4.76 | -4.6 | -2.45 | 3.7 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 30 | 27 | 25 | 25 | 25 | 25 |
Shares Outstanding (Diluted) | 30 | 27 | 25 | 25 | 25 | 25 |
Shares Change | 18.64% | 9.54% | 0.04% | - | -1.06% | 1.07% |
EPS (Basic) | -0.35 | -0.30 | -0.19 | -0.19 | -0.10 | 0.15 |
EPS (Diluted) | -0.35 | -0.30 | -0.19 | -0.19 | -0.10 | 0.15 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -11.84 | -10.31 | 3.09 | -0.86 | -1.67 | 0.37 |
Free Cash Flow Per Share | -0.40 | -0.38 | 0.12 | -0.04 | -0.07 | 0.01 |
Gross Margin | 36.22% | 36.29% | 43.64% | 40.58% | 44.26% | 47.49% |
Operating Margin | -38.26% | -26.34% | -19.14% | -17.70% | -9.54% | -5.01% |
Profit Margin | -42.28% | -30.47% | -21.04% | -18.29% | -9.79% | 15.15% |
Free Cash Flow Margin | -48.16% | -38.09% | 13.67% | -3.44% | -6.67% | 1.53% |
EBITDA | -8.5 | -6.25 | -3.78 | -3.88 | -1.96 | -0.75 |
EBITDA Margin | -34.58% | -23.10% | -16.69% | -15.44% | -7.83% | -3.08% |
D&A For EBITDA | 0.91 | 0.88 | 0.55 | 0.57 | 0.43 | 0.47 |
EBIT | -9.41 | -7.13 | -4.33 | -4.45 | -2.39 | -1.22 |
EBIT Margin | -38.26% | -26.34% | -19.14% | -17.70% | -9.54% | -5.01% |
Effective Tax Rate | - | - | - | - | - | 0.52% |
Revenue as Reported | 24.58 | 27.07 | 22.62 | 25.14 | 25 | 24.4 |
Advertising Expenses | - | 0.13 | 0.07 | 0.08 | 0.05 | 0.05 |